Protocol Page


	Study ID (Protocol Number)
	CA209-009


	STUDY LOCATIONS*
	Dana Farber Cancer Inst Boston, MA 02215 Recruiting	Duke University Medical Center Durham, NC 27710 Recruiting
	Dana Farber Cancer Inst Boston, MA 02215 Recruiting	Fox Chase Cancer Center Philadelphia, PA 19111 Recruiting
	*Not all study site locations may be listed - please check back soon for updated information. For more information regarding other participating countries, please visit clinicaltrials.gov.

	STUDY NAME
	Phase I Biomarker Study (BMS-936558)
	STUDY OVERVIEW
	The purpose of this study is to evaluate the pharmacodynamic and biologic properties of BMS-936558 in subjects with metastatic renal cell carcinoma.

The study information provided here is a portion of what is available on ClinicalTrials.gov. Please visit ClinicalTrials.gov for complete information about this and other clinical studies.